Adjusted Revenue

Adjusted Revenue %Chg

Adjusted Gross Profit

Adjusted Gross Profit %Chg

Adjusted Gross Margin

Adjusted Gross Margin %Chg

Adjusted EBIT

Adjusted EBIT %Chg

Adjusted EBIT Margin

Adjusted EBIT Margin %Chg

Adjusted EBITDA

Adjusted EBITDA %Chg

Adjusted EBITDA Margin

Adjusted EBITDA Margin %Chg

Adjusted Net Income

Adjusted Net Income %Chg

Adjusted Net Income Margin

Adjusted Net Income Margin %Chg

Adjusted EPS

Adjusted EPS %Chg

Adjusted Free Cash Flow (FCF)

Adjusted Free Cash Flow (FCF) %Chg

Adjusted Free Cash Flow Margin

Adjusted Free Cash Flow Margin %Chg

Adjusted Capital Expenditures

Adjusted Capital Expenditures %Chg

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Metric	Dec '26 (E)	Sep '26 (E)	Jun '26 (E)	Mar '26 (E)	Dec '25 (E)	Sep '25	Jun '25	Mar '25	Dec '24	Sep '24	Jun '24	Mar '24	Dec '23	Oct '23	Jul '23	Apr '23	Dec '22	Oct '22	Jul '22	Apr '22	Dec '21	Oct '21	Jul '21	Apr '21	Dec '20
Adjusted Revenue					18,935
Adjusted Gross Profit					—
Adjusted Gross Margin					—
Adjusted EBIT					5,109.5
Adjusted EBIT Margin					27%
Adjusted EBITDA					6,048
Adjusted EBITDA Margin					31.9%
Adjusted Net Income					3,288
Adjusted Net Income Margin					17.4%
Adjusted EPS					0.6
Adjusted Free Cash Flow (FCF)					—
Adjusted Free Cash Flow Margin					—
Adjusted Capital Expenditures					-614